mRNA cancer vaccine slashes melanoma death or recurrence risk by 42%
Moderna CEO Stephane Bancel said the findings open a new chapter in cancer treatment
How sure are we
Two or more outlets reported this story and its reliability score reached 65%, so WorldPulse marks it verified. That means more than one outlet says so, not that it is proven true.
Who reported it
[Claude] Both other reports cover the same trial result, a 42% cut in melanoma death or recurrence risk, with no conflicting facts.
3d ago[Claude] Report 2 covers the same melanoma vaccine trial result, a 42% reduction in death or recurrence risk, reported from a market angle without contradicting Report 1.
4d agoAlso reported by ksl.com (found in GDELT's list of news articles)
4d agoScore bands
What moves the score
Not in the score: AI checks and reader flags. Verified is separate: two or more independent outlets and a score of at least 65%.
Very high · How we score this